Robert Hershberg - 02 Feb 2023 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Director
Signature
/s/ Robert Hershberg by Eric Billings, Attorney-in-Fact
Issuer symbol
ADPT
Transactions as of
02 Feb 2023
Net transactions value
+$23,850
Form type
4
Filing time
03 Feb 2023, 16:00:37 UTC
Previous filing
03 Feb 2023
Next filing
08 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Options Exercise $23,850 +53,000 +647% $0.4500* 61,193 02 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -53,000 -100% $0.000000* 0 02 Feb 2023 Common Stock 53,000 $0.4500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is fully vested and exercisable.